Pharmaceutical Contract Development & Manufacturing Market 2027 By Service, End User and Geography | The Insight Partners

Pharmaceutical Contract Development & Manufacturing Market to 2027 - Global Analysis and Forecasts By Service (Drug Development Services, Biologics Manufacturing Services, and Pharmaceutical Manufacturing Services); End User (Generic Pharmaceutical Companies, Small & Mid-Size Pharmaceutical Companies and Big Pharmaceutical Companies) and Geography

Report Code: TIPRE00006706 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming
MARKET INTRODUCTION

Pharmaceutical contract development & manufacturing services refer to the process of development of drugs or APIs. With an increase in R&D expenditure and manufacturing costs, there has been a rise in the preference for development and manufacturing of pharmaceutical products on a contract basis. The increase in the number of pharmaceutical companies is expected to drive the growth of the market during the forecast period.

MARKET DYNAMICS

The pharmaceutical contract development & manufacturing market is anticipated to grow in the forecast, owing to increasing investments in pharmaceutical R&D and investments in advanced manufacturing technologies by CDMOs. Also, increasing focus on specialty medicines is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Global Pharmaceutical Contract Development & Manufacturing Market Analysis to 2027" is a specialized and in-depth study of the healthcare IT industry with a special focus on the global market trend analysis. The report aims to provide an overview of pharmaceutical contract development & manufacturing market with detailed market segmentation by service, end user and geography. The global pharmaceutical contract development & manufacturing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading pharmaceutical contract development & manufacturing market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global pharmaceutical contract development & manufacturing market is segmented on the basis of service and end user. Based on service the market is segmented as, drug development services, biologics manufacturing services, and pharmaceutical manufacturing services. The pharmaceutical contract development & manufacturing market is categorized based on end user such as, generic pharmaceutical companies, small & mid-size pharmaceutical companies and big pharmaceutical companies.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global pharmaceutical contract development & manufacturing market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pharmaceutical contract development & manufacturing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting pharmaceutical contract development & manufacturing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pharmaceutical contract development & manufacturing market in these regions.


MARKET PLAYERS


The report covers key developments in the pharmaceutical contract development & manufacturing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pharmaceutical contract development & manufacturing market are anticipated to have lucrative growth opportunities in the future with the rising demand for pharmaceutical contract development & manufacturing market in the global market. Below mentioned is the list of few companies engaged in the pharmaceutical contract development & manufacturing market.

The report also includes the profiles of key pharmaceutical contract development & manufacturing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  AbbVie Inc.
  •  Almac Group
  •  Catalent, Inc.
  •  Evonik
  •  Lonza
  •  Recipharm AB (publ)
  •  Siegfried AG
  •  The Aenova Group
  •  Thermo Fisher Scientific Inc.
  •  Vetter

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pharmaceutical Contract Development & Manufacturing Market - By Service
1.3.2 Pharmaceutical Contract Development & Manufacturing Market - By End User
1.3.3 Pharmaceutical Contract Development & Manufacturing Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET - GLOBAL MARKET ANALYSIS

6.1. PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING - GLOBAL MARKET OVERVIEW
6.2. PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET - REVENUE AND FORECASTS TO 2027 - SERVICE

7.1. OVERVIEW
7.2. SERVICE MARKET FORECASTS AND ANALYSIS
7.3. DRUG DEVELOPMENT SERVICES
7.3.1. Overview
7.3.2. Drug Development Services Market Forecast and Analysis
7.4. BIOLOGICS MANUFACTURING SERVICES
7.4.1. Overview
7.4.2. Biologics Manufacturing Services Market Forecast and Analysis
7.4.3. Biologics FDF Manufacturing Services Market
7.4.3.1. Overview
7.4.3.2. Biologics FDF Manufacturing Services Market Forecast and Analysis
7.4.4. Biologics API Manufacturing Services Market
7.4.4.1. Overview
7.4.4.2. Biologics API Manufacturing Services Market Forecast and Analysis
7.5. PHARMACEUTICAL MANUFACTURING SERVICES
7.5.1. Overview
7.5.2. Pharmaceutical Manufacturing Services Market Forecast and Analysis
7.5.3. Pharmaceutical API Manufacturing Services Market
7.5.3.1. Overview
7.5.3.2. Pharmaceutical API Manufacturing Services Market Forecast and Analysis
7.5.4. Pharmaceutical FDF Manufacturing Services Market
7.5.4.1. Overview
7.5.4.2. Pharmaceutical FDF Manufacturing Services Market Forecast and Analysis
7.5.4.3. Capsule Manufacturing Services Market Forecast and Analysis
7.5.4.3.1. Overview
7.5.4.3.2. Capsule Manufacturing Services Market Forecast and Analysis
7.5.4.4. Parenteral/Injectable Manufacturing Services Market Forecast and Analysis
7.5.4.4.1. Overview
7.5.4.4.2. Parenteral/Injectable Manufacturing Services Market Forecast and Analysis
7.5.4.5. Oral Liquid Manufacturing Services Market Forecast and Analysis
7.5.4.5.1. Overview
7.5.4.5.2. Oral Liquid Manufacturing Services Market Forecast and Analysis
7.5.4.6. Other Formulations Manufacturing Services Market Forecast and Analysis
7.5.4.6.1. Overview
7.5.4.6.2. Other Formulations Manufacturing Services Market Forecast and Analysis

8. PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. GENERIC PHARMACEUTICAL COMPANIES
8.3.1. Overview
8.3.2. Generic Pharmaceutical Companies Market Forecast and Analysis
8.4. SMALL & MID-SIZE PHARMACEUTICAL COMPANIES
8.4.1. Overview
8.4.2. Small & Mid-Size Pharmaceutical Companies Market Forecast and Analysis
8.5. BIG PHARMACEUTICAL COMPANIES
8.5.1. Overview
8.5.2. Big Pharmaceutical Companies Market Forecast and Analysis

9. PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

9.1. NORTH AMERICA
9.1.1 North America Pharmaceutical Contract Development & Manufacturing Market Overview
9.1.2 North America Pharmaceutical Contract Development & Manufacturing Market Forecasts and Analysis
9.1.3 North America Pharmaceutical Contract Development & Manufacturing Market Forecasts and Analysis - By Service
9.1.4 North America Pharmaceutical Contract Development & Manufacturing Market Forecasts and Analysis - By End User
9.1.5 North America Pharmaceutical Contract Development & Manufacturing Market Forecasts and Analysis - By Countries
9.1.5.1 United States Pharmaceutical Contract Development & Manufacturing Market
9.1.5.1.1 United States Pharmaceutical Contract Development & Manufacturing Market by Service
9.1.5.1.2 United States Pharmaceutical Contract Development & Manufacturing Market by End User
9.1.5.2 Canada Pharmaceutical Contract Development & Manufacturing Market
9.1.5.2.1 Canada Pharmaceutical Contract Development & Manufacturing Market by Service
9.1.5.2.2 Canada Pharmaceutical Contract Development & Manufacturing Market by End User
9.1.5.3 Mexico Pharmaceutical Contract Development & Manufacturing Market
9.1.5.3.1 Mexico Pharmaceutical Contract Development & Manufacturing Market by Service
9.1.5.3.2 Mexico Pharmaceutical Contract Development & Manufacturing Market by End User
9.2. EUROPE
9.2.1 Europe Pharmaceutical Contract Development & Manufacturing Market Overview
9.2.2 Europe Pharmaceutical Contract Development & Manufacturing Market Forecasts and Analysis
9.2.3 Europe Pharmaceutical Contract Development & Manufacturing Market Forecasts and Analysis - By Service
9.2.4 Europe Pharmaceutical Contract Development & Manufacturing Market Forecasts and Analysis - By End User
9.2.5 Europe Pharmaceutical Contract Development & Manufacturing Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Pharmaceutical Contract Development & Manufacturing Market
9.2.5.1.1 Germany Pharmaceutical Contract Development & Manufacturing Market by Service
9.2.5.1.2 Germany Pharmaceutical Contract Development & Manufacturing Market by End User
9.2.5.2 France Pharmaceutical Contract Development & Manufacturing Market
9.2.5.2.1 France Pharmaceutical Contract Development & Manufacturing Market by Service
9.2.5.2.2 France Pharmaceutical Contract Development & Manufacturing Market by End User
9.2.5.3 Italy Pharmaceutical Contract Development & Manufacturing Market
9.2.5.3.1 Italy Pharmaceutical Contract Development & Manufacturing Market by Service
9.2.5.3.2 Italy Pharmaceutical Contract Development & Manufacturing Market by End User
9.2.5.4 Spain Pharmaceutical Contract Development & Manufacturing Market
9.2.5.4.1 Spain Pharmaceutical Contract Development & Manufacturing Market by Service
9.2.5.4.2 Spain Pharmaceutical Contract Development & Manufacturing Market by End User
9.2.5.5 United Kingdom Pharmaceutical Contract Development & Manufacturing Market
9.2.5.5.1 United Kingdom Pharmaceutical Contract Development & Manufacturing Market by Service
9.2.5.5.2 United Kingdom Pharmaceutical Contract Development & Manufacturing Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Pharmaceutical Contract Development & Manufacturing Market Overview
9.3.2 Asia-Pacific Pharmaceutical Contract Development & Manufacturing Market Forecasts and Analysis
9.3.3 Asia-Pacific Pharmaceutical Contract Development & Manufacturing Market Forecasts and Analysis - By Service
9.3.4 Asia-Pacific Pharmaceutical Contract Development & Manufacturing Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Pharmaceutical Contract Development & Manufacturing Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Pharmaceutical Contract Development & Manufacturing Market
9.3.5.1.1 Australia Pharmaceutical Contract Development & Manufacturing Market by Service
9.3.5.1.2 Australia Pharmaceutical Contract Development & Manufacturing Market by End User
9.3.5.2 China Pharmaceutical Contract Development & Manufacturing Market
9.3.5.2.1 China Pharmaceutical Contract Development & Manufacturing Market by Service
9.3.5.2.2 China Pharmaceutical Contract Development & Manufacturing Market by End User
9.3.5.3 India Pharmaceutical Contract Development & Manufacturing Market
9.3.5.3.1 India Pharmaceutical Contract Development & Manufacturing Market by Service
9.3.5.3.2 India Pharmaceutical Contract Development & Manufacturing Market by End User
9.3.5.4 Japan Pharmaceutical Contract Development & Manufacturing Market
9.3.5.4.1 Japan Pharmaceutical Contract Development & Manufacturing Market by Service
9.3.5.4.2 Japan Pharmaceutical Contract Development & Manufacturing Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Pharmaceutical Contract Development & Manufacturing Market Overview
9.4.2 Middle East and Africa Pharmaceutical Contract Development & Manufacturing Market Forecasts and Analysis
9.4.3 Middle East and Africa Pharmaceutical Contract Development & Manufacturing Market Forecasts and Analysis - By Service
9.4.4 Middle East and Africa Pharmaceutical Contract Development & Manufacturing Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Pharmaceutical Contract Development & Manufacturing Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Pharmaceutical Contract Development & Manufacturing Market
9.4.5.1.1 South Africa Pharmaceutical Contract Development & Manufacturing Market by Service
9.4.5.1.2 South Africa Pharmaceutical Contract Development & Manufacturing Market by End User
9.4.5.2 Saudi Arabia Pharmaceutical Contract Development & Manufacturing Market
9.4.5.2.1 Saudi Arabia Pharmaceutical Contract Development & Manufacturing Market by Service
9.4.5.2.2 Saudi Arabia Pharmaceutical Contract Development & Manufacturing Market by End User
9.4.5.3 U.A.E Pharmaceutical Contract Development & Manufacturing Market
9.4.5.3.1 U.A.E Pharmaceutical Contract Development & Manufacturing Market by Service
9.4.5.3.2 U.A.E Pharmaceutical Contract Development & Manufacturing Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Pharmaceutical Contract Development & Manufacturing Market Overview
9.5.2 South and Central America Pharmaceutical Contract Development & Manufacturing Market Forecasts and Analysis
9.5.3 South and Central America Pharmaceutical Contract Development & Manufacturing Market Forecasts and Analysis - By Service
9.5.4 South and Central America Pharmaceutical Contract Development & Manufacturing Market Forecasts and Analysis - By End User
9.5.5 South and Central America Pharmaceutical Contract Development & Manufacturing Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Pharmaceutical Contract Development & Manufacturing Market
9.5.5.1.1 Brazil Pharmaceutical Contract Development & Manufacturing Market by Service
9.5.5.1.2 Brazil Pharmaceutical Contract Development & Manufacturing Market by End User
9.5.5.2 Argentina Pharmaceutical Contract Development & Manufacturing Market
9.5.5.2.1 Argentina Pharmaceutical Contract Development & Manufacturing Market by Service
9.5.5.2.2 Argentina Pharmaceutical Contract Development & Manufacturing Market by End User

10. INDUSTRY LANDSCAPE

10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET, KEY COMPANY PROFILES

11.1. ABBVIE INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ALMAC GROUP
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CATALENT, INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. EVONIK
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. LONZA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. RECIPHARM AB (PUBL)
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SIEGFRIED AG
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. THE AENOVA GROUP
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. THERMO FISHER SCIENTIFIC INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. VETTER
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX

12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. AbbVie Inc.
2. Almac Group
3. Catalent, Inc.
4. Evonik
5. Lonza
6. Recipharm AB (publ)
7. Siegfried AG
8. The Aenova Group
9. Thermo Fisher Scientific Inc.
10. Vetter